progress of knowledge each generation has a double labour-to escape from the intellectual thralls of the one from which it has emerged and to forge anew its own fetters.' For this occasion I would paraphrase Osler's sarcastic and rather gloomy statement as follows: Every practitioner has to fight a battle on two fronts;' on the one hand against the erroneous views of preceding generations, though retaining what has proved to be right and, on the other, against the ever increasing flow of new therapeutic methods, in an attempt to separate the grain from the abundant chaff. Our main weapon in this fight is a critical attitude based on knowledge of the subject.
Our enemies on the first front are Authority, Tradition and Routine. Today we shall not dwell on this aspect of the battle; suffice it to say that defeat can only be avoided by examining ourselves every day as to the usefulness of what we are doing.
Today we shall have a look at the other front, but with respect to the short time available restrict ourselves to a few aspects only. We cannot discuss the risks inherent to the introduction of any new drug, neither can we discuss the economic and ethical aspects.
It is my task to discuss the criteria to be used in deciding whether a given medicine is effective or not-a discussion which is indeed limited in its scope, although it should be pointed out that the above mentioned criteria do not apply only to the evaluation of drugs, but can also be used, though with a different accent, in evaluating other modes of therapy such as physiotherapy, surgical and dietetic treatment and maybe psychotherapy.
In my opinion, evaluation on the whole is simpler where drug treatment is concerned, although it is still difficult and in some cases even almost impossible.
It may be useful, first, to discuss with you the phases in the establishment of a drug. It is developed in the research laboratories of the large pharmaceutic industries, tested in scores of animal experiments, tried out more or less cautiously as a research preparation on normal subjects and subsequently on patients. Then the birth of the new drug is announced more or less soberly in the scientific press or perhaps even in the Reader's Digest, unless the announcement reaches the medical profession via the radio or television. And then the new drug begins its career. Jawetz-a well- The need for great caution is illustrated by the investigation of the American Heart Association into the value of anticoagulants in the treatment of myocardial infarction. These anticoagulants were given to patients admitted on odd days, those admitted on even days serving as controls. At the end of the experiment it was found that the treated group was considerably larger than the control group and included a considerably larger number of 'private patients' with private nurses. This was found to be due to the fact that the arrangements for the experiment became known through rumours, so that several practitioners saw to it that their patients were admitted on an odd day. As a result, the two groups were not comparable and the conclusions reached less reliable.
Nor is it permissible to use patients in one hospital serving as controls for patients in another hospital, without certain provisions. The groups may be dissimilar due to differences in social conditions. Results may furthermore be seriously influenced by differences in nursing. The statistician will even frown upon comparisons between two wards in the same hospital.
In the above examples, there is a trend towards taking the control group composition at random, but there are flaws in the execution of the plan. A great many investigators, however, seem to be completely ignorant of this requirement, as may be shown by the following examples:
An investigator treats a group of ulcer patients by a rest-and-diet cure, and observes that the results are more favourable in fresh cases than in cases of long standing. His conclusions are as follows: (I) this therapy is effective, and (2) the sooner it is started, the greater its efficacy. In fact, the investigator has done this: he compares early 400 POSTGRADUATE MEDICAL JOURNAL August i957 cases (with a better chance of spontaneous cure) with chronic cases (in which part of the possibility of spontaneous cure has been lost). Such a comparison is, ofcourse, unjustifiable and the conclusion -although possibly correct in itself-is no proof.
Another investigator compares the results obtained in a group of ulcer patients, who kept to a prescribed diet, with a group of ulcer patients who gave up the diet, and concludes that keeping to the diet prevents relapses. Again a conclusion which is not justifiable. Can these two groups be compared, and why did not the second group keep to the diet? The results presented by an investigator who ignores the requirement of simultaneous controls at random should be mistrusted, unless he is able to present sound reasons for having deviated from this rule in his special case.
Is it sufficient, therefore, to arrange the experiment so as to ensure that one group is treated with the drug to be tested, while the other group is not? In principle it is, but results, if any, must not be attributed exclusively to the pharmacological effect of the drug tried out. The effect of any drug is a composite one. Besides the pharmacological it has a magic effect, which is based on the patient's confidence in the efficacy of the drug, and on his confidence-still widespread in spite of everything -in the skill and knowledge of his doctor.
This magic effect is today referred to as the placebo effect, which is often underrated both by the patient and by the physician.
Of late, much has been written about the psychology of the placebo. The 
